Scientists discovered that certain gene changes allow cells to function even when frataxin, the protein lost in Friedreich’s ...
The FDA has granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...
The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...
Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results